TD Cowen Downgrades 2seventy bio to Market Perform
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Yaron Werber has downgraded 2seventy bio (NASDAQ:TSVT) from Outperform to Market Perform, indicating a change in the stock's expected performance.
January 31, 2024 | 10:28 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
2seventy bio has been downgraded by TD Cowen from Outperform to Market Perform, which may influence investors' perception of the stock.
Downgrades by analysts can lead to a negative short-term reaction in the stock market as they suggest a less optimistic outlook on the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100